Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Better Therapeutics, Inc. | Chief Product Officer | Common Stock | 225,631 | $38.3 K | $0.17 | Dec 18, 2023 | Direct |
Better Therapeutics, Inc. | Chief Product Officer | Stock Option (Right to Buy) | 101,450 | Mar 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BTTX | Better Therapeutics, Inc. | Dec 18, 2023 | 1 | 0 | 4 | Dec 20, 2023 | Chief Product Officer |
BTTX | Better Therapeutics, Inc. | Mar 1, 2023 | 2 | 0 | 4 | Apr 21, 2023 | Chief Product Officer |
BTTX | Better Therapeutics, Inc. | May 31, 2022 | 2 | 12,420 | 4 | Dec 2, 2022 | Chief Product Officer |
BTTX | Better Therapeutics, Inc. | Apr 1, 2022 | 1 | 0 | 4 | Apr 4, 2022 | Chief Product Officer |
BTTX | Better Therapeutics, Inc. | Oct 28, 2021 | 0 | 0 | 3 | Nov 1, 2021 | Chief Product Officer |